Clinical Trials on Convalescent Plasma in Canada
Total 283 results
-
Harrison, Theodore, M.D.Unknown
-
AEterna ZentarisCompletedMultiple Myeloma and Plasma Cell NeoplasmCanada
-
National Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaCanada
-
St. Boniface HospitalAgriculture and Agri-Food CanadaActive, not recruiting
-
Mayo ClinicNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States, Canada
-
University of CalgaryCompletedWhiplash Injuries | Neck Injuries | Platelet Rich PlasmaCanada
-
Centre hospitalier de l'Université de Montréal...Spine Intervention Society; Association Québécoise Médecine Sportive et ExerciceCompletedLow Back Pain | Zygapophyseal Joint Arthritis | Platelet Rich PlasmaCanada
-
NCIC Clinical Trials GroupCompletedMultiple Myeloma and Plasma Cell NeoplasmCanada
-
NCIC Clinical Trials GroupNational Cancer Institute (NCI); Eastern Cooperative Oncology GroupCompletedMultiple Myeloma and Plasma Cell NeoplasmCanada
-
Canadian Cancer Trials GroupCanadian Institutes of Health Research (CIHR); Myeloma CanadaRecruiting
-
Mansoura UniversityActive, not recruitingErectile Dysfunction Following Radiation Therapy | Phosphodiesterase Inhibitor Adverse Reaction | Platelet- Rich Plasma (PRP)Egypt
-
University of AlbertaNot yet recruitingMultiple Myeloma | Exercise | PrehabilitationCanada
-
University Health Network, TorontoMultiple Myeloma Research ConsortiumTerminatedMultiple Myeloma | Relapsed/RefractoryCanada
-
CancerCare ManitobaCompletedLymphoma | Multiple MyelomaCanada
-
Ciusss de L'Est de l'Île de MontréalExCellThera inc.; Centre C3iActive, not recruitingMultiple MyelomaCanada
-
University of AlbertaCompleted
-
AHS Cancer Control AlbertaAbbott; Tom Baker Cancer CentreCompleted
-
AHS Cancer Control AlbertaTom Baker Cancer CentreRecruitingMyeloma | Myeloma MultipleCanada
-
Ottawa Hospital Research InstituteRecruiting
-
Maisonneuve-Rosemont HospitalCompletedMultiple Myeloma | High-Risk CancerCanada
-
Dr. Nicole Culos-ReedCompletedHematologic Neoplasms | Multiple Myeloma | Advanced CancerCanada
-
University of CalgaryRecruitingSickle Cell Disease | Pure Red Cell Aplasia | Stem Cell Transplant Complications | Red Blood Cell DisorderCanada
-
NCIC Clinical Trials GroupCompletedPain | Lymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Small Intestine Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous/Nonmalignant ConditionCanada
-
University of British ColumbiaTerminatedAnti-Xa ActivityCanada
-
NCIC Clinical Trials GroupCompletedMultiple Myeloma and Plasma Cell NeoplasmCanada, United States
-
University Health Network, TorontoCompletedMultiple Myeloma | AmyloidosisCanada
-
Ciusss de L'Est de l'Île de MontréalCelgene; C3i Center Inc.Active, not recruitingMultiple Myeloma | Relapsed Hematologic MalignancyCanada
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI); European Organisation for Research and Treatment... and other collaboratorsCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States, Canada
-
NCIC Clinical Trials GroupCompletedMultiple Myeloma and Plasma Cell NeoplasmCanada, United States
-
University Health Network, TorontoCompletedMultiple Myeloma | Renal FailureCanada
-
Genzyme, a Sanofi CompanyCompletedLymphoma, Non-Hodgkin | Multiple MyelomaCanada
-
PETHEMA FoundationBristol-Myers Squibb; Celgene; Adknoma Health Research, S.L.TerminatedMultiple MyelomaSpain
-
Canadian Myeloma Research GroupMerck Sharp & Dohme LLCWithdrawn
-
Alberta Health Services, CalgaryAlberta Cancer Foundation; University of VictoriaRecruitingLymphoma | Leukemia | Multiple Myeloma | Blood Cancer | Stem Cell Transplant Complications | Chimeric Antigen Receptor T-cell TherapyCanada
-
London Health Sciences CentreCanadian Institutes of Health Research (CIHR); The Kidney Foundation of CanadaCompletedMultiple Myeloma | Acute Renal FailureCanada
-
Emory UniversityMillennium Pharmaceuticals, Inc.; Ortho Biotech, Inc.CompletedProtocol of the Combination of Bortezomib and Tipifarnib for Relapsed or Refractory Multiple MyelomaMultiple MyelomaUnited States, Canada
-
Multiple Myeloma Research FoundationActive, not recruiting
-
GlaxoSmithKlineTerminatedRelapsed/Refractory Multiple MyelomaAustralia, Sweden, Canada
-
Lawson Health Research InstituteThe Ottawa Hospital; Hamilton Health Sciences Corporation; Dalhousie University; Niagara Health SystemActive, not recruitingMultiple Myeloma in Relapse | Multiple Myeloma With Failed Remission | Multiple Myeloma Stage I | Multiple Myeloma Progression | Multiple Myeloma Stage II | Multiple Myeloma Stage IIICanada
-
Janssen-Ortho Inc., CanadaOrtho Biotech CanadaNo longer available
-
AllerganCompleted
-
Washington University School of MedicineBristol-Myers Squibb; CelgeneActive, not recruitingMultiple Myeloma in RelapseUnited States, Canada
-
University Health Network, TorontoPrincess Margaret Hospital, CanadaCompletedLymphoma | Multiple Myeloma | Influenza A Virus, H1N1 SubtypeCanada
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedPure Red-cell AplasiaUnited Kingdom, Sweden, South Africa, Brazil, Canada, Germany, Norway, Thailand
-
University of British ColumbiaUnknownVitiligo | Melasma | Lichen Planus PigmentosusCanada
-
University of AlbertaSocial Sciences and Humanities Research Council of CanadaRecruitingMelanoma | Cancer | Breast Cancer | Multiple Myeloma | Colorectal Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Chronic Leukemia | Tyrosine Kinase MutationCanada
-
University of ChicagoNational Cancer Institute (NCI); Multiple Myeloma Research FoundationRecruitingMultiple MyelomaUnited States, Canada
-
SanofiRecruitingPlasma Cell Myeloma RecurrentUnited States, Argentina, Australia, Brazil, Canada, Chile, China, Czechia, France, Germany, Greece, Hungary, Italy, Japan, Norway, Poland, Spain, Sweden, Taiwan, Turkey, United Kingdom
-
NCIC Clinical Trials GroupAstex Pharmaceuticals, Inc.Completed
-
University Health Network, TorontoPrincess Margaret Hospital, Canada; Ortho Biotech, Inc.Completed